lipid-regulating drugs

lipid-regulating drugs

drugs used to lower blood concentration of low-density lipoproteins and raise concentration of high-density lipoproteins, to reduce atheroma formation; see statins
Mentioned in ?
References in periodicals archive ?
For QuatRx, this addition to our portfolio represents an outstanding fit with our growing dyslipidemia portfolio and our team's experience in developing successful lipid-regulating drugs, including Lipitor[R], the number-one cholesterol medicine in the world.
We are pleased to have a company such as QuatRx Pharmaceuticals take this platform forward, given that the team there has considerable experience in developing lipid-regulating drugs.
Global sales of lipid-regulating drugs are currently estimated to exceed $20 billion annually, and continue to grow rapidly.